FCC ID VN5-CPB

VN5CPB, VN5 CPB, VN5-CPB, VNS-CPB

Ascensia Diabetes Care US Inc. Blood glucose monitoring system CPB

An FCC ID is the product ID assigned by the FCC to identify wireless products in the market. The FCC chooses 3 or 5 character "Grantee" codes to identify the business that created the product. For example, the grantee code for FCC ID: VN5-CPB is VN5. The remaining characters of the FCC ID, -CPB, are often associated with the product model, but they can be random. These letters are chosen by the applicant. In addition to the application, the FCC also publishes internal images, external images, user manuals, and test results for wireless devices. They can be under the "exhibits" tab below.

Purchase on Amazon: Blood glucose monitoring system

Application: Blood glucose monitoring system
Equipment Class: DTS - Digital Transmission System
Short Link: fcc.id/VN5-CPB
Sources: FCC.gov | FCC.report
Registered By: Ascensia Diabetes Care US Inc. - VN5 (United States)

App #	Purpose	Date	Unique ID
1	Original Equipment	2024-09-20	JrXareV2Dg0ikc70e4asmA==

Operating Frequencies

Frequency Range	Power Output	Rule Parts	Line Entry
2.402-2.48 GHz	1 mW	15C	1

Exhibits

Document	Type	Submitted Available
Device Label and Location	ID Label/Location Info Adobe Acrobat PDF (157 kB)	2024-09-11 2024-09-20
FCC Agent for service Attestation	Attestation Statements Adobe Acrobat PDF (108 kB)	2024-09-11 2024-09-20
Attestation	Attestation Statements Adobe Acrobat PDF (108 kB)	2024-09-11 2024-09-20
Request for Confidentiality	Cover Letter(s) Adobe Acrobat PDF (116 kB)	2024-09-11 2024-09-20
FCC Agent Auth Letter	Cover Letter(s) Adobe Acrobat PDF (110 kB)	2024-09-11 2024-09-20
FCC BLE REPORT	Test Report Adobe Acrobat PDF (2315 kB)	2024-09-11 2024-09-20
FCC MPE REPORT	RF Exposure Info Adobe Acrobat PDF (377 kB)	2024-09-11 2024-09-20
Thunder_Antenna_Spec	Test Report Adobe Acrobat PDF (1078 kB)	2024-09-11 2024-09-20
Setup Photos_Antenna	Test Setup Photos Adobe Acrobat PDF (149 kB)	2024-09-11 2025-01-16
Block Diagram	Block Diagram Adobe Acrobat PDF (113 kB)	2024-09-11
Internal photos	Internal Photos Adobe Acrobat PDF (2771 kB)	2024-09-11 2025-01-16
Schematics	Schematics Adobe Acrobat PDF (2225 kB)	2024-09-11
User Guide	Users Manual Adobe Acrobat PDF (1059 kB)	2024-09-11 2025-01-16
BLE SETUP PHOTOS	Test Setup Photos Adobe Acrobat PDF (1094 kB)	2024-09-11 2025-01-16
External photos	External Photos Adobe Acrobat PDF (2019 kB)	2024-09-11 2025-01-16
Operational description	Operational Description Adobe Acrobat PDF (81 kB)	2024-09-11

Application Forms

1 (2024-09-20)

Application for Equipment Authorization FCC Form 731 TCB Version

Applicant Information

Applicant's complete, legal business name:	Ascensia Diabetes Care US Inc.
FCC Registration Number (FRN):	0016907776
Alphanumeric FCC ID:	VN5CPB
Unique Application Identifier:	JrXareV2Dg0ikc70e4asmA==
Line one:	5 Wood Hollow Road
City:	Parsippany
State:	New Jersey
Country:	United States
Zip Code:	07054

TCB Information

TCB Application Email Address:	LST.FRE.CertNotice@ul.com
TCB Scope:	A4: UNII devices & low power transmitters using spread spectrum techniques

FCC ID

Grantee Code:	VN5
Product Code:	-CPB

Person at the applicant's address to receive grant or for contact

Name:	Ben Hostetler
Title:	Global Program Team - Quality Lead

Telephone Number:

574-314-9618

Extension:

Fax Number:	574-314-9618
Email:	ben.hostetler@ascensia.com

Long-Term Confidentiality

Does this application include a request for confidentiality for any portion(s) of the data contained in this application pursuant to 47 CFR § 0.459 of the Commission Rules?: Yes

Short-Term Confidentiality

Does short-term confidentiality apply to this application?: Yes

If so, specify the short-term confidentiality release date (MM/DD/YYYY format): 01/16/2025
Note: If no date is supplied, the release date will be set to 45 calendar days past the date of grant.

Software Defined/Cognitive Radio

Is this application for software defined/cognitive radio authorization? No

Equipment Class

Equipment Class: DTS - Digital Transmission System
Description of product as it is marketed: (NOTE: This text will appear below the equipment class on the grant):	Blood glucose monitoring system

Related OET KnowledgeDataBase Inquiry

Is there a KDB inquiry associated with this application? No

Modular Equipment

Modular Type: Does not apply

Application Purpose

Application is for: Original Equipment

Composite/Related Equipment

Is the equipment in this application a composite device subject to an additional equipment authorization? No

Is the equipment in this application part of a system that operates with, or is marketed with, another device that requires an equipment authorization? No

Test Firm Information

Name of test firm and contact person on file with the FCC:

Firm Name: UL LLC

First Name: Steven

Last Name: Thompson

Telephone Number:

919 549 1430

Extension:

E-mail: steven.d.thompson@ul.com

Grant Comments

Enter any text that you would like to appear at the bottom of the Grant of Equipment Authorization:
Power output listed is conducted.

Set the grant of this application to be deferred to a specified date:
No

Equipment Authorization Waiver

Is there an equipment authorization waiver associated with this application? No

If there is an equipment authorization waiver associated with this application, has the associated waiver been approved and all information uploaded?: No

WILLFUL FALSE STATEMENTS MADE ON THIS FORM ARE PUNISHABLE BY FINE AND IMPRISONMENT (U.S. CODE, TITLE 18, SECTION 1001), AND/OR REVOCATION OF ANY STATION LICENSE OR CONSTRUCTION PERMIT (U.S. CODE, TITLE 47, SECTION 312(a)(1)), AND/OR FORFEITURE (U.S. CODE, TITLE 47, SECTION 503).

SECTION 5301 (ANTI-DRUG ABUSE) CERTIFICATION:

The applicant must certify that neither the applicant nor any party to the application is subject to a denial of Federal benefits, that include FCC benefits, pursuant to Section 5301 of the Anti-Drug Abuse Act of 1988, 21 U.S.C. § 862 because of a conviction for possession or distribution of a controlled substance. See 47 CFR 1.2002(b) for the definition of a "party" for these purposes.

Does the applicant or authorized agent so certify? Yes

Applicant/Agent Certification:

I certify that I am authorized to sign this application. All of the statements herein and the exhibits attached hereto, are true and correct to the best of my knowledge and belief. In accepting a Grant of Equipment Authorization as a result of the representations made in this application, the applicant is responsible for (1) labeling the equipment with the exact FCC ID specified in this application, (2) compliance statement labeling pursuant to the applicable rules, and (3) compliance of the equipment with the applicable technical rules. If the applicant is not the actual manufacturer of the equipment, appropriate arrangements have been made with the manufacturer to ensure that production units of this equipment will continue to comply with the FCC's technical requirements.

Authorizing an agent to sign this application, is done solely at the applicant's discretion; however, the applicant remains responsible for all statements in this application.

If an agent has signed this application on behalf of the applicant, a written letter of authorization which includes information to enable the agent to respond to the above section 5301 (Anti-Drug Abuse) Certification statement has been provided by the applicant. It is understood that the letter of authorization must be submitted to the FCC upon request, and that the FCC reserves the right to contact the applicant directly at any time.

Signature of Authorized Person Filing: Ben Hostetler

Title of authorized signature:

Applications are submitted for FCC ID and Grant requests. Click an above application to view details

TCB	GRANT OF EQUIPMENT AUTHORIZATION	TCB
Certification
Issued Under the Authority of the
Federal Communications Commission
By:

UL Verification Services Inc.
47173 Benicia Street
Fremont, CA 94538

Date of Grant: 09/20/2024

Application Dated: 09/11/2024

Ascensia Diabetes Care US Inc.

5 Wood Hollow Road

Parsippany, NJ 07054

Attention: Ben Hostetler , Global Program Team - Quality Lead

NOT TRANSFERABLE

EQUIPMENT AUTHORIZATION is hereby issued to the named GRANTEE, and is VALID ONLY for the equipment identified hereon for use under the Commission's Rules and Regulations listed below.

FCC IDENTIFIER:	VN5-CPB

Name of Grantee:	Ascensia Diabetes Care US Inc.

Equipment Class:	Digital Transmission System
Notes:	Blood glucose monitoring system

Grant Notes	FCC Rule Parts	Frequency Range (MHZ)	Output Watts	Frequency Tolerance	Emission Designator
	15C	2402.0 - 2480.0	0.001

Power output listed is conducted.

COPY	FEDERAL COMMUNICATIONS COMMISSION WASHINGTON, D.C. 20554 GRANT OF EQUIPMENT AUTHORIZATION	COPY
Certification

Ascensia Diabetes Care US Inc.
5 Wood Hollow Road
Parsippany, NJ 07054
United States